These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2025495)

  • 1. Diarylsulfonylureas and radiotherapy. I. In vitro studies with N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea (Sulofenur).
    Rockwell S; Grindey GB
    Cancer Commun; 1991 Apr; 3(4):103-8. PubMed ID: 2025495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
    Houghton PJ; Bailey FC; Germain GS; Grindey GB; Witt BC; Houghton JA
    Cancer Res; 1990 Jan; 50(2):318-22. PubMed ID: 2295071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
    Sosinski J; Thakar JH; Germain GS; Dias P; Harwood FC; Kuttesch JF; Houghton PJ
    Mol Pharmacol; 1994 May; 45(5):962-70. PubMed ID: 7910660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.
    Houghton PJ; Sosinski J; Thakar JH; Boder GB; Grindey GB
    Biochem Pharmacol; 1995 Mar; 49(5):661-8. PubMed ID: 7887981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas.
    Ehlhardt WJ; Woodland JM; Worzalla JF; Bewley JR; Grindey GB; Todd GC; Toth JE; Howbert JJ
    Chem Res Toxicol; 1992; 5(5):667-73. PubMed ID: 1446007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells.
    Rush GF; Rinzel S; Boder G; Heim RA; Toth JE; Ponsler GD
    Biochem Pharmacol; 1992 Dec; 44(12):2387-94. PubMed ID: 1472104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions.
    Thakar JH; Chapin C; Berg RH; Ashmun RA; Houghton PJ
    Cancer Res; 1991 Dec; 51(23 Pt 1):6286-91. PubMed ID: 1933889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of the novel sulphonylurea sulofenur in advanced breast cancer.
    Talbot DC; Smith IE; Nicolson MC; Powles TJ; Button D; Walling J
    Cancer Chemother Pharmacol; 1993; 31(5):419-22. PubMed ID: 8431978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action.
    Sosinski J; Thakar JH; Germain GS; Harwood FC; Houghton PJ
    Biochem Pharmacol; 1993 May; 45(10):2135-42. PubMed ID: 8512595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione and mercapturic acid conjugates of sulofenur and their activity against a human colon cancer cell line.
    Guan X; Hoffman BN; McFarland DC; Gilkerson KK; Dwivedi C; Erickson AK; Bebensee S; Pellegrini J
    Drug Metab Dispos; 2002 Mar; 30(3):331-5. PubMed ID: 11854154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-dependent metabolism of the antitumor agent sulofenur. Evidence for the formation of p-chlorophenyl isocyanate as a reactive intermediate.
    Jochheim CM; Davis MR; Baillie KM; Ehlhardt WJ; Baillie TA
    Chem Res Toxicol; 2002 Feb; 15(2):240-8. PubMed ID: 11849051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts.
    Houghton PJ; Cheshire PJ; Myers L; Lutz L; Toth J; Grindey GB; Houghton JA
    Anticancer Drugs; 1995 Apr; 6(2):317-23. PubMed ID: 7795279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of BMS-181174 and radiation: studies with EMT6 cells in vitro and in solid tumors.
    Rockwell S; Kelley M
    Radiother Oncol; 1996 Apr; 39(1):65-71. PubMed ID: 8735495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with radiation, mitomycin C, and 5-fluorouracil in EMT6 tumors.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):127-33. PubMed ID: 8270433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the anticancer agent sulofenur in mice, rats, monkeys, and dogs.
    Ehlhardt WJ; Sullivan HR; Wood PG; Woodland JM; Hamilton M; Hamilton C; Cornpropst D; Grindey GB; Worzalla JF; Bewley JR
    J Pharm Sci; 1993 Jul; 82(7):683-8. PubMed ID: 8360840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of albumin on antitumor activity of diarylsulfonylureas.
    Schultz RM; Andis SL; Toth JE; Boder GB; Rinzel SM; Grindey GB
    Anticancer Res; 1993; 13(6A):1939-43. PubMed ID: 8297099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and disposition of the anticancer agent sulofenur in mouse, rat, monkey, and human.
    Ehlhardt WJ
    Drug Metab Dispos; 1991; 19(2):370-5. PubMed ID: 1676639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of sulofenur in refractory pediatric malignant solid tumors.
    Pratt CB; Bowman LC; Marina N; Pappo A; Avery L; Luo X; Meyer WH
    Invest New Drugs; 1995; 13(1):63-6. PubMed ID: 7499110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylureas: a new class of cancer chemotherapeutic agents.
    Mohamadi F; Spees MM; Grindey GB
    J Med Chem; 1992 Aug; 35(16):3012-6. PubMed ID: 1501228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.